Loading...
Header Logo
Keywords
Last Name
Institution

JEFFREY MORRIS

TitleProfessor
InstitutionMD Anderson
DepartmentBiostatistics
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Morris JS, Gutstein HB. Detection and Quantification of Protein Spots by Pinnacle. Methods Mol Biol. 2016; 1384:185-201. PMID: 26611416.
      View in: PubMed
    2. Abdel-Wahab R, Shehata S, Hassan MM, Xiao L, Lee JS, Cheung S, Essa HH, Hassabo HM, Shalaby AS, Mosad E, Raghav K, Rashid A, Wolff RA, Morris JS, Amin HM, Kaseb AO. Validation of an IGF-CTP scoring system for assessing hepatic reserve in Egyptian patients with hepatocellular carcinoma. Oncotarget. 2015 Aug 28; 6(25):21193-207. PMID: 26098859.
      View in: PubMed
    3. Hassan MM, Abdel-Wahab R, Kaseb A, Shalaby A, Phan AT, El-Serag HB, Hawk E, Morris J, Singh Raghav KP, Lee JS, Vauthey JN, Bortus G, Torres HA, Amos CI, Wolff RA, Li D. Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma. Gastroenterology. 2015 Jul; 149(1):119-29. PMID: 25836985.
      View in: PubMed
    4. Zhang L, Morris JS, Zhang J, Orlowski RZ, Baladandayuthapani V. Bayesian joint selection of genes and pathways: applications in multiple myeloma genomics. Cancer Inform. 2014; 13(Suppl 2):113-23. PMID: 25520554.
      View in: PubMed
    5. Tudor S, Giza DE, Lin HY, Fabris L, Yoshiaki K, D'Abundo L, Toale KM, Shimizu M, Ferracin M, Challagundla KB, Cortez MA, Fuentes-Mattei E, Tulbure D, Gonzalez C, Henderson J, Row M, Rice TW, Ivan C, Negrini M, Fabbri M, Morris JS, Yeung SC, Vasilescu C, Calin GA. Cellular and Kaposi's sarcoma-associated herpes virus microRNAs in sepsis and surgical trauma. Cell Death Dis. 2014 Dec 04; 5:e1559. PMID: 25476907.
      View in: PubMed
    6. Kee BK, Morris JS, Slack RS, Crocenzi T, Wong L, Esparaz B, Overman M, Glover K, Jones D, Wen S, Fisch MJ. A phase II, randomized, double blind trial of calcium aluminosilicate clay versus placebo for the prevention of diarrhea in patients with metastatic colorectal cancer treated with irinotecan. Support Care Cancer. 2015 Mar; 23(3):661-70. PMID: 25160493.
      View in: PubMed
    7. Jeter CB, Patel SS, Morris JS, Chuang AZ, Butler IJ, Sereno AB. Oculomotor executive function abnormalities with increased tic severity in Tourette syndrome. J Child Psychol Psychiatry. 2015 Feb; 56(2):193-202. PMID: 25040172.
      View in: PubMed
    8. Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia T, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. J Natl Cancer Inst. 2014 May 09; 106(5). PMID: 24815863.
      View in: PubMed
    9. Zuo X, Xu M, Yu J, Wu Y, Moussalli MJ, Manyam GC, Lee SI, Liang S, Gagea M, Morris JS, Broaddus RR, Shureiqi I. Potentiation of colon cancer susceptibility in mice by colonic epithelial PPAR-d/ß overexpression. J Natl Cancer Inst. 2014 Apr; 106(4):dju052. PMID: 24681603.
      View in: PubMed
    10. Kaseb AO, Shah NN, Hassabo HM, Morris JS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley S, Abbruzzese JL, Hassan MM. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology. 2014; 86(2):63-71. PMID: 24401634.
      View in: PubMed
    11. Raghav KP, Shetty AV, Kazmi SM, Zhang N, Morris J, Taggart M, Fournier K, Royal R, Mansfield P, Eng C, Wolff RA, Overman MJ. Impact of molecular alterations and targeted therapy in appendiceal adenocarcinomas. Oncologist. 2013; 18(12):1270-7. PMID: 24149137.
      View in: PubMed
    12. Lieu CH, Tran H, Jiang ZQ, Mao M, Overman MJ, Lin E, Eng C, Morris J, Ellis L, Heymach JV, Kopetz S. The association of alternate VEGF ligands with resistance to anti-VEGF therapy in metastatic colorectal cancer. PLoS One. 2013; 8(10):e77117. PMID: 24143206.
      View in: PubMed
    13. Jennings EM, Morris JS, Carroll RJ, Manyam GC, Baladandayuthapani V. Bayesian methods for expression-based integration of various types of genomics data. EURASIP J Bioinform Syst Biol. 2013 Sep 21; 2013(1):13. PMID: 24053265.
      View in: PubMed
    14. Eberth JM, Eschbach K, Morris JS, Nguyen HT, Hossain MM, Elting LS. Geographic disparities in mammography capacity in the South: a longitudinal assessment of supply and demand. Health Serv Res. 2014 Feb; 49(1):171-85. PMID: 23829179.
      View in: PubMed
    15. Lynch PM, Morris JS, Ross WA, Rodriguez-Bigas MA, Posadas J, Khalaf R, Weber DM, Sepeda VO, Levin B, Shureiqi I. Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool. Gastrointest Endosc. 2013 Mar; 77(3):455-63. PMID: 23332604.
      View in: PubMed
    16. Wang W, Baladandayuthapani V, Morris JS, Broom BM, Manyam G, Do KA. iBAG: integrative Bayesian analysis of high-dimensional multiplatform genomics data. Bioinformatics. 2013 Jan 15; 29(2):149-59. PMID: 23142963.
      View in: PubMed
    17. Zhu H, Brown PJ, Morris JS. Robust classification of functional and quantitative image data using functional mixed models. Biometrics. 2012 Dec; 68(4):1260-8. PMID: 22670567.
      View in: PubMed
    18. Zuo X, Peng Z, Wu Y, Moussalli MJ, Yang XL, Wang Y, Parker-Thornburg J, Morris JS, Broaddus RR, Fischer SM, Shureiqi I. Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in mice. J Natl Cancer Inst. 2012 May 02; 104(9):709-16. PMID: 22472308.
      View in: PubMed
    19. Kaseb AO, Garrett-Mayer E, Morris JS, Xiao L, Lin E, Onicescu G, Hassan MM, Hassabo HM, Iwasaki M, Deaton FL, Abbruzzese JL, Thomas MB. Efficacy of bevacizumab plus erlotinib for advanced hepatocellular carcinoma and predictors of outcome: final results of a phase II trial. Oncology. 2012; 82(2):67-74. PMID: 22327795.
      View in: PubMed
    20. Sabath N, Morris JS, Graur D. Is there a twelfth protein-coding gene in the genome of influenza A? A selection-based approach to the detection of overlapping genes in closely related sequences. J Mol Evol. 2011 Dec; 73(5-6):305-15. PMID: 22187135.
      View in: PubMed
    21. Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol. 2011 Oct 10; 29(29):3892-9. PMID: 21911725.
      View in: PubMed
    22. Moussalli MJ, Wu Y, Zuo X, Yang XL, Wistuba II, Raso MG, Morris JS, Bowser JL, Minna JD, Lotan R, Shureiqi I. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion. Cancer Prev Res (Phila). 2011 Dec; 4(12):1961-72. PMID: 21881028.
      View in: PubMed
    23. Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score. Oncology. 2011; 80(5-6):373-81. PMID: 21822028.
      View in: PubMed
    24. Fogelman D, Jafari M, Varadhachary GR, Xiong H, Bullock S, Ozer H, Lin E, Morris J, Cunningham P, Bennett B, Abbruzzese JL, Wolff RA. Bevacizumab plus gemcitabine and oxaliplatin as first-line therapy for metastatic or locally advanced pancreatic cancer: a phase II trial. Cancer Chemother Pharmacol. 2011 Dec; 68(6):1431-8. PMID: 21479635.
      View in: PubMed
    25. Diao L, Clarke CH, Coombes KR, Hamilton SR, Roth J, Mao L, Czerniak B, Baggerly KA, Morris JS, Fung ET, Bast RC. Reproducibility of SELDI Spectra Across Time and Laboratories. Cancer Inform. 2011 Mar 14; 10:45-64. PMID: 21552492.
      View in: PubMed
    26. Kaseb AO, Hassan MM, Lin E, Xiao L, Kumar V, Pathak P, Lozano R, Rashid A, Abbruzzese JL, Morris JS. V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials. Cancer. 2011 Jun 01; 117(11):2478-88. PMID: 24048796.
      View in: PubMed
    27. Dowsey AW, English JA, Lisacek F, Morris JS, Yang GZ, Dunn MJ. Image analysis tools and emerging algorithms for expression proteomics. Proteomics. 2010 Dec; 10(23):4226-57. PMID: 21046614.
      View in: PubMed
    28. Waddell T, Gollins S, Soe W, Valle J, Allen J, Bentley D, Morris J, Lloyd A, Swindell R, Taylor MB, Saunders MP. Phase II study of short-course capecitabine plus oxaliplatin (XELOX) followed by maintenance capecitabine in advanced colorectal cancer: XelQuali study. Cancer Chemother Pharmacol. 2011 May; 67(5):1111-7. PMID: 20676676.
      View in: PubMed
    29. Katz RL, He W, Khanna A, Fernandez RL, Zaidi TM, Krebs M, Caraway NP, Zhang HZ, Jiang F, Spitz MR, Blowers DP, Jimenez CA, Mehran RJ, Swisher SG, Roth JA, Morris JS, Etzel CJ, El-Zein R. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res. 2010 Aug 01; 16(15):3976-87. PMID: 20651054.
      View in: PubMed
    30. Shureiqi I, Chen D, Day RS, Zuo X, Hochman FL, Ross WA, Cole RA, Moy O, Morris JS, Xiao L, Newman RA, Yang P, Lippman SM. Profiling lipoxygenase metabolism in specific steps of colorectal tumorigenesis. Cancer Prev Res (Phila). 2010 Jul; 3(7):829-38. PMID: 20570882.
      View in: PubMed
    31. Malloy EJ, Morris JS, Adar SD, Suh H, Gold DR, Coull BA. Wavelet-based functional linear mixed models: an application to measurement error-corrected distributed lag models. Biostatistics. 2010 Jul; 11(3):432-52. PMID: 20156988.
      View in: PubMed
    32. Morris JS, Clark BN, Wei W, Gutstein HB. Evaluating the performance of new approaches to spot quantification and differential expression in 2-dimensional gel electrophoresis studies. J Proteome Res. 2010 Jan; 9(1):595-604. PMID: 19919108.
      View in: PubMed
    33. Morris JS, Baggerly KA, Gutstein HB, Coombes KR. Statistical contributions to proteomic research. Methods Mol Biol. 2010; 641:143-66. PMID: 20407946.
      View in: PubMed
    34. Dowsey AW, Morris JS, Gutstein HB, Yang GZ. Informatics and statistics for analyzing 2-d gel electrophoresis images. Methods Mol Biol. 2010; 604:239-55. PMID: 20013375.
      View in: PubMed
    35. Kopetz S, Hoff PM, Morris JS, Wolff RA, Eng C, Glover KY, Adinin R, Overman MJ, Valero V, Wen S, Lieu C, Yan S, Tran HT, Ellis LM, Abbruzzese JL, Heymach JV. Phase II trial of infusional fluorouracil, irinotecan, and bevacizumab for metastatic colorectal cancer: efficacy and circulating angiogenic biomarkers associated with therapeutic resistance. J Clin Oncol. 2010 Jan 20; 28(3):453-9. PMID: 20008624.
      View in: PubMed
    36. Cradock AL, Melly SJ, Allen JG, Morris JS, Gortmaker SL. Youth destinations associated with objective measures of physical activity in adolescents. J Adolesc Health. 2009 Sep; 45(3 Suppl):S91-8. PMID: 19699443.
      View in: PubMed
    37. Gollins SW, Myint S, Susnerwala S, Haylock B, Wise M, Topham C, Samuel L, Swindell R, Morris J, Mason L, Levine E. Preoperative downstaging chemoradiation with concurrent irinotecan and capecitabine in MRI-defined locally advanced rectal cancer: a phase I trial (NWCOG-2). Br J Cancer. 2009 Sep 15; 101(6):924-34. PMID: 19690550.
      View in: PubMed
    38. Li D, Morris JS, Liu J, Hassan MM, Day RS, Bondy ML, Abbruzzese JL. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009 Jun 24; 301(24):2553-62. PMID: 19549972.
      View in: PubMed
    39. Zuo X, Peng Z, Moussalli MJ, Morris JS, Broaddus RR, Fischer SM, Shureiqi I. Targeted genetic disruption of peroxisome proliferator-activated receptor-delta and colonic tumorigenesis. J Natl Cancer Inst. 2009 May 20; 101(10):762-7. PMID: 19436036.
      View in: PubMed
    40. Fleming JB, Gonzalez RJ, Petzel MQ, Lin E, Morris JS, Gomez H, Lee JE, Crane CH, Pisters PW, Evans DB. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg. 2009 Mar; 144(3):216-21. PMID: 19289659.
      View in: PubMed
    41. Zuo X, Morris JS, Broaddus R, Shureiqi I. 15-LOX-1 transcription suppression through the NuRD complex in colon cancer cells. Oncogene. 2009 Mar 26; 28(12):1496-505. PMID: 19198625.
      View in: PubMed
    42. Kamat P, Wen S, Morris J, Anandasabapathy S. Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis. Ann Thorac Surg. 2009 Feb; 87(2):655-62. PMID: 19161814.
      View in: PubMed
    43. Overman MJ, Varadhachary GR, Kopetz S, Adinin R, Lin E, Morris JS, Eng C, Abbruzzese JL, Wolff RA. Phase II study of capecitabine and oxaliplatin for advanced adenocarcinoma of the small bowel and ampulla of Vater. J Clin Oncol. 2009 Jun 01; 27(16):2598-603. PMID: 19164203.
      View in: PubMed
    44. Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, Li Y, Chang P, Abbruzzese JL. DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res. 2009 Jan 15; 15(2):740-6. PMID: 19147782.
      View in: PubMed
    45. Thomas MB, Morris JS, Chadha R, Iwasaki M, Kaur H, Lin E, Lin E, Kaseb A, Glover K, Davila M, Abbruzzese J. Phase II trial of the combination of bevacizumab and erlotinib in patients who have advanced hepatocellular carcinoma. J Clin Oncol. 2009 Feb 20; 27(6):843-50. PMID: 19139433.
      View in: PubMed
    46. Overman MJ, Kopetz S, Wen S, Hoff PM, Fogelman D, Morris J, Abbruzzese JL, Ajani JA, Wolff RA. Chemotherapy with 5-fluorouracil and a platinum compound improves outcomes in metastatic small bowel adenocarcinoma. Cancer. 2008 Oct 15; 113(8):2038-45. PMID: 18759326.
      View in: PubMed
    47. Zuo X, Morris JS, Shureiqi I. Chromatin modification requirements for 15-lipoxygenase-1 transcriptional reactivation in colon cancer cells. J Biol Chem. 2008 Nov 14; 283(46):31341-7. PMID: 18799463.
      View in: PubMed
    48. Gutstein HB, Morris JS, Annangudi SP, Sweedler JV. Microproteomics: analysis of protein diversity in small samples. Mass Spectrom Rev. 2008 Jul-Aug; 27(4):316-30. PMID: 18271009.
      View in: PubMed
    49. Suzuki H, Morris JS, Li Y, Doll MA, Hein DW, Liu J, Jiao L, Hassan MM, Day RS, Bondy ML, Abbruzzese JL, Li D. Interaction of the cytochrome P4501A2, SULT1A1 and NAT gene polymorphisms with smoking and dietary mutagen intake in modification of the risk of pancreatic cancer. Carcinogenesis. 2008 Jun; 29(6):1184-91. PMID: 18499698.
      View in: PubMed
    50. Suehiro Y, Wong CW, Chirieac LR, Kondo Y, Shen L, Webb CR, Chan YW, Chan AS, Chan TL, Wu TT, Rashid A, Hamanaka Y, Hinoda Y, Shannon RL, Wang X, Morris J, Issa JP, Yuen ST, Leung SY, Hamilton SR. Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma. Clin Cancer Res. 2008 May 01; 14(9):2560-9. PMID: 18451217.
      View in: PubMed
    51. Wu Y, Fang B, Yang XQ, Wang L, Chen D, Krasnykh V, Carter BZ, Morris JS, Shureiqi I. Therapeutic molecular targeting of 15-lipoxygenase-1 in colon cancer. Mol Ther. 2008 May; 16(5):886-92. PMID: 18388920.
      View in: PubMed
    52. Zuo X, Shen L, Issa JP, Moy O, Morris JS, Lippman SM, Shureiqi I. 15-Lipoxygenase-1 transcriptional silencing by DNA methyltransferase-1 independently of DNA methylation. FASEB J. 2008 Jun; 22(6):1981-92. PMID: 18198215.
      View in: PubMed
    53. Morris JS, Clark BN, Gutstein HB. Pinnacle: a fast, automatic and accurate method for detecting and quantifying protein spots in 2-dimensional gel electrophoresis data. Bioinformatics. 2008 Feb 15; 24(4):529-36. PMID: 18194961.
      View in: PubMed
    54. Gutstein HB, Morris JS. Laser capture sampling and analytical issues in proteomics. Expert Rev Proteomics. 2007 Oct; 4(5):627-37. PMID: 17941818.
      View in: PubMed
    55. Chan AO, Jim MH, Lam KF, Morris JS, Siu DC, Tong T, Ng FH, Wong SY, Hui WM, Chan CK, Lai KC, Cheung TK, Chan P, Wong G, Yuen MF, Lau YK, Lee S, Szeto ML, Wong BC, Lam SK. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary artery disease. JAMA. 2007 Sep 26; 298(12):1412-9. PMID: 17895457.
      View in: PubMed
    56. Morris JS, Brown PJ, Herrick RC, Baggerly KA, Coombes KR. Bayesian analysis of mass spectrometry proteomic data using wavelet-based functional mixed models. Biometrics. 2008 Jun; 64(2):479-89. PMID: 17888041.
      View in: PubMed
    57. Thomas MB, Chadha R, Glover K, Wang X, Morris J, Brown T, Rashid A, Dancey J, Abbruzzese JL. Phase 2 study of erlotinib in patients with unresectable hepatocellular carcinoma. Cancer. 2007 Sep 01; 110(5):1059-67. PMID: 17623837.
      View in: PubMed
    58. Patel PR, Mansfield PF, Crane CH, Wu TT, Lee JH, Lynch PM, Morris J, Pisters PW, Feig B, Sunder PK, Izzo JG, Ajani JA. Clinical stage after preoperative chemoradiation is a better predictor of patient outcome than the baseline stage for localized gastric cancer. Cancer. 2007 Sep 01; 110(5):989-95. PMID: 17636525.
      View in: PubMed
    59. Cradock AL, Melly SJ, Allen JG, Morris JS, Gortmaker SL. Characteristics of school campuses and physical activity among youth. Am J Prev Med. 2007 Aug; 33(2):106-113. PMID: 17673097.
      View in: PubMed
    60. Song JJ, Lee HJ, Morris JS, Kang S. Clustering of time-course gene expression data using functional data analysis. Comput Biol Chem. 2007 Aug; 31(4):265-74. PMID: 17631419.
      View in: PubMed
    61. Anandasabapathy S, Jhamb J, Davila M, Wei C, Morris J, Bresalier R. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia. Cancer. 2007 Feb 15; 109(4):668-74. PMID: 17211862.
      View in: PubMed
    62. Shureiqi I, Zuo X, Broaddus R, Wu Y, Guan B, Morris JS, Lippman SM. The transcription factor GATA-6 is overexpressed in vivo and contributes to silencing 15-LOX-1 in vitro in human colon cancer. FASEB J. 2007 Mar; 21(3):743-53. PMID: 17167069.
      View in: PubMed
    63. Karpievitch YV, Hill EG, Smolka AJ, Morris JS, Coombes KR, Baggerly KA, Almeida JS. PrepMS: TOF MS data graphical preprocessing tool. Bioinformatics. 2007 Jan 15; 23(2):264-5. PMID: 17121773.
      View in: PubMed
    64. Krishnan S, Janjan NA, Skibber JM, Rodriguez-Bigas MA, Wolff RA, Das P, Delclos ME, Chang GJ, Hoff PM, Eng C, Brown TD, Crane CH, Feig BW, Morris J, Vadhan-Raj S, Hamilton SR, Lin EH. Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced rectal cancer. Int J Radiat Oncol Biol Phys. 2006 Nov 01; 66(3):762-71. PMID: 17011451.
      View in: PubMed
    65. Rohatgi PR, Mansfield PF, Crane CH, Wu TT, Sunder PK, Ross WA, Morris JS, Pisters PW, Feig BW, Gunderson LL, Ajani JA. Surgical pathology stage by American Joint Commission on Cancer criteria predicts patient survival after preoperative chemoradiation for localized gastric carcinoma. Cancer. 2006 Oct 01; 107(7):1475-82. PMID: 16944539.
      View in: PubMed
    66. Lin EH, Curley SA, Crane CC, Feig B, Skibber J, Delcos M, Vadhan SR, Morris J, Ayers GD, Ross A, Brown T, Rodriguez-Bigas MA, Janjan N. Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol. 2006 Jun; 29(3):232-9. PMID: 16755175.
      View in: PubMed
    67. Mayo MS, Gajewski BJ, Morris JS. Some statistical issues in microarray gene expression data. Radiat Res. 2006 Jun; 165(6):745-8. PMID: 16802876.
      View in: PubMed
    68. Zuo X, Wu Y, Morris JS, Stimmel JB, Leesnitzer LM, Fischer SM, Lippman SM, Shureiqi I. Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene. 2006 Feb 23; 25(8):1225-41. PMID: 16288226.
      View in: PubMed
    69. Shureiqi I, Wu Y, Chen D, Yang XL, Guan B, Morris JS, Yang P, Newman RA, Broaddus R, Hamilton SR, Lynch P, Levin B, Fischer SM, Lippman SM. The critical role of 15-lipoxygenase-1 in colorectal epithelial cell terminal differentiation and tumorigenesis. Cancer Res. 2005 Dec 15; 65(24):11486-92. PMID: 16357157.
      View in: PubMed
    70. Coombes KR, Tsavachidis S, Morris JS, Baggerly KA, Hung MC, Kuerer HM. Improved peak detection and quantification of mass spectrometry data acquired from surface-enhanced laser desorption and ionization by denoising spectra with the undecimated discrete wavelet transform. Proteomics. 2005 Nov; 5(16):4107-17. PMID: 16254928.
      View in: PubMed
    71. Hong D, Lunagomez S, Kim EE, Lee JH, Bresalier RS, Swisher SG, Wu TT, Morris J, Liao Z, Komaki R, Ajani JA. Value of baseline positron emission tomography for predicting overall survival in patient with nonmetastatic esophageal or gastroesophageal junction carcinoma. Cancer. 2005 Oct 15; 104(8):1620-6. PMID: 16118804.
      View in: PubMed
    72. Semmes OJ, Cazares LH, Ward MD, Qi L, Moody M, Maloney E, Morris J, Trosset MW, Hisada M, Gygi S, Jacobson S. Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic disease. Leukemia. 2005 Jul; 19(7):1229-38. PMID: 15889159.
      View in: PubMed
    73. Chirieac LR, Swisher SG, Ajani JA, Komaki RR, Correa AM, Morris JS, Roth JA, Rashid A, Hamilton SR, Wu TT. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005 Apr 01; 103(7):1347-55. PMID: 15719440.
      View in: PubMed
    74. Beach R, Chan AO, Wu TT, White JA, Morris JS, Lunagomez S, Broaddus RR, Issa JP, Hamilton SR, Rashid A. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005 Apr; 166(4):1069-75. PMID: 15793287.
      View in: PubMed
    75. Coombes KR, Morris JS, Hu J, Edmonson SR, Baggerly KA. Serum proteomics profiling--a young technology begins to mature. Nat Biotechnol. 2005 Mar; 23(3):291-2. PMID: 15765078.
      View in: PubMed
    76. Ajani JA, Mansfield PF, Crane CH, Wu TT, Lunagomez S, Lynch PM, Janjan N, Feig B, Faust J, Yao JC, Nivers R, Morris J, Pisters PW. Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol. 2005 Feb 20; 23(6):1237-44. PMID: 15718321.
      View in: PubMed
    77. Baggerly KA, Morris JS, Edmonson SR, Coombes KR. Signal in noise: evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J Natl Cancer Inst. 2005 Feb 16; 97(4):307-9. PMID: 15713966.
      View in: PubMed
    78. Hu J, Coombes KR, Morris JS, Baggerly KA. The importance of experimental design in proteomic mass spectrometry experiments: some cautionary tales. Brief Funct Genomic Proteomic. 2005 Feb; 3(4):322-31. PMID: 15814023.
      View in: PubMed
    79. Madoff DC, Abdalla EK, Gupta S, Wu TT, Morris JS, Denys A, Wallace MJ, Morello FA, Ahrar K, Murthy R, Lunagomez S, Hicks ME, Vauthey JN. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol. 2005 Feb; 16(2 Pt 1):215-25. PMID: 15713922.
      View in: PubMed
    80. Morris JS, Coombes KR, Koomen J, Baggerly KA, Kobayashi R. Feature extraction and quantification for mass spectrometry in biomedical applications using the mean spectrum. Bioinformatics. 2005 May 01; 21(9):1764-75. PMID: 15673564.
      View in: PubMed
    81. Baggerly KA, Edmonson SR, Morris JS, Coombes KR. High-resolution serum proteomic patterns for ovarian cancer detection. Endocr Relat Cancer. 2004 Dec; 11(4):583-4; author reply 585-7. PMID: 15613439.
      View in: PubMed
    82. Baggerly KA, Deng L, Morris JS, Aldaz CM. Overdispersed logistic regression for SAGE: modelling multiple groups and covariates. BMC Bioinformatics. 2004 Oct 06; 5:144. PMID: 15469612.
      View in: PubMed
    83. Kalha I, Kaw M, Fukami N, Patel M, Singh S, Gagneja H, Cohen D, Morris J. The accuracy of endoscopic ultrasound for restaging esophageal carcinoma after chemoradiation therapy. Cancer. 2004 Sep 01; 101(5):940-7. PMID: 15329901.
      View in: PubMed
    84. Ajani JA, Mansfield PF, Janjan N, Morris J, Pisters PW, Lynch PM, Feig B, Myerson R, Nivers R, Cohen DS, Gunderson LL. Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma. J Clin Oncol. 2004 Jul 15; 22(14):2774-80. PMID: 15254045.
      View in: PubMed
    85. Ajani JA, Walsh G, Komaki R, Morris J, Swisher SG, Putnam JB, Lynch PM, Wu TT, Smythe R, Vaporciyan A, Faust J, Cohen DS, Nivers R, Roth JA. Preoperative induction of CPT-11 and cisplatin chemotherapy followed by chemoradiotherapy in patients with locoregional carcinoma of the esophagus or gastroesophageal junction. Cancer. 2004 Jun 01; 100(11):2347-54. PMID: 15160337.
      View in: PubMed
    86. Sinicrope FA, Half E, Morris JS, Lynch PM, Morrow JD, Levin B, Hawk ET, Cohen DS, Ayers GD, Stephens LC. Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev. 2004 Jun; 13(6):920-7. PMID: 15184247.
      View in: PubMed
    87. Baggerly KA, Morris JS, Coombes KR. Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments. Bioinformatics. 2004 Mar 22; 20(5):777-85. PMID: 14751995.
      View in: PubMed
    88. Pawlik TM, Izzo F, Cohen DS, Morris JS, Curley SA. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003 Nov; 10(9):1059-69. PMID: 14597445.
      View in: PubMed
    89. Pawlik TM, Paulino AF, McGinn CJ, Baker LH, Cohen DS, Morris JS, Rees R, Sondak VK. Cutaneous angiosarcoma of the scalp: a multidisciplinary approach. Cancer. 2003 Oct 15; 98(8):1716-26. PMID: 14534889.
      View in: PubMed
    90. Coombes KR, Fritsche HA, Clarke C, Chen JN, Baggerly KA, Morris JS, Xiao LC, Hung MC, Kuerer HM. Quality control and peak finding for proteomics data collected from nipple aspirate fluid by surface-enhanced laser desorption and ionization. Clin Chem. 2003 Oct; 49(10):1615-23. PMID: 14500586.
      View in: PubMed
    91. Morris JS, Baggerly KA, Coombes KR. Bayesian shrinkage estimation of the relative abundance of mRNA transcripts using SAGE. Biometrics. 2003 Sep; 59(3):476-86. PMID: 14601748.
      View in: PubMed
    92. Baggerly KA, Morris JS, Wang J, Gold D, Xiao LC, Coombes KR. A comprehensive approach to the analysis of matrix-assisted laser desorption/ionization-time of flight proteomics spectra from serum samples. Proteomics. 2003 Sep; 3(9):1667-72. PMID: 12973722.
      View in: PubMed
    93. Baggerly KA, Deng L, Morris JS, Aldaz CM. Differential expression in SAGE: accounting for normal between-library variation. Bioinformatics. 2003 Aug 12; 19(12):1477-83. PMID: 12912827.
      View in: PubMed
    94. Shureiqi I, Jiang W, Zuo X, Wu Y, Stimmel JB, Leesnitzer LM, Morris JS, Fan HZ, Fischer SM, Lippman SM. The 15-lipoxygenase-1 product 13-S-hydroxyoctadecadienoic acid down-regulates PPAR-delta to induce apoptosis in colorectal cancer cells. Proc Natl Acad Sci U S A. 2003 Aug 19; 100(17):9968-73. PMID: 12909723.
      View in: PubMed
    95. Madoff DC, Hicks ME, Abdalla EK, Morris JS, Vauthey JN. Portal vein embolization with polyvinyl alcohol particles and coils in preparation for major liver resection for hepatobiliary malignancy: safety and effectiveness--study in 26 patients. Radiology. 2003 Apr; 227(1):251-60. PMID: 12616006.
      View in: PubMed
    96. Switzer KC, McMurray DN, Morris JS, Chapkin RS. (n-3) Polyunsaturated fatty acids promote activation-induced cell death in murine T lymphocytes. J Nutr. 2003 Feb; 133(2):496-503. PMID: 12566490.
      View in: PubMed
    97. Morris JS, Wang N, Lupton JR, Chapkin RS, Turner ND, Hong MY, Carroll RJ. Understanding the relationship between carcinogen-induced DNA adduct levels in distal and proximal regions of the colon. Adv Exp Med Biol. 2003; 537:105-16. PMID: 14995031.
      View in: PubMed
    98. Hong MY, Chapkin RS, Davidson LA, Turner ND, Morris JS, Carroll RJ, Lupton JR. Fish oil enhances targeted apoptosis during colon tumor initiation in part by downregulating Bcl-2. Nutr Cancer. 2003; 46(1):44-51. PMID: 12925303.
      View in: PubMed
    99. Lin E, Morris JS, Ayers GD. Effect of celecoxib on capecitabine-induced hand-foot syndrome and antitumor activity. Oncology (Williston Park). 2002 Dec; 16(12 Suppl No 14):31-7. PMID: 12520638.
      View in: PubMed
    100. Chan AO, Issa JP, Morris JS, Hamilton SR, Rashid A. Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol. 2002 Feb; 160(2):529-36. PMID: 11839573.
      View in: PubMed
    101. Hong MY, Chapkin RS, Morris JS, Wang N, Carroll RJ, Turner ND, Chang WC, Davidson LA, Lupton JR. Anatomical site-specific response to DNA damage is related to later tumor development in the rat azoxymethane colon carcinogenesis model. Carcinogenesis. 2001 Nov; 22(11):1831-5. PMID: 11698346.
      View in: PubMed
    102. Arrington JL, Chapkin RS, Switzer KC, Morris JS, McMurray DN. Dietary n-3 polyunsaturated fatty acids modulate purified murine T-cell subset activation. Clin Exp Immunol. 2001 Sep; 125(3):499-507. PMID: 11531960.
      View in: PubMed
    103. Rashid A, Shen L, Morris JS, Issa JP, Hamilton SR. CpG island methylation in colorectal adenomas. Am J Pathol. 2001 Sep; 159(3):1129-35. PMID: 11549606.
      View in: PubMed
    104. Shureiqi I, Cooksley CD, Morris J, Soliman AS, Levin B, Lippman SM. Effect of age on risk of second primary colorectal cancer. J Natl Cancer Inst. 2001 Aug 15; 93(16):1264-6. PMID: 11504772.
      View in: PubMed
    105. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, Fischer SM, Lippman SM. Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res. 2001 Jun 15; 61(12):4879-84. PMID: 11406566.
      View in: PubMed
    106. Hong MY, Lupton JR, Morris JS, Wang N, Carroll RJ, Davidson LA, Elder RH, Chapkin RS. Dietary fish oil reduces O6-methylguanine DNA adduct levels in rat colon in part by increasing apoptosis during tumor initiation. Cancer Epidemiol Biomarkers Prev. 2000 Aug; 9(8):819-26. PMID: 10952099.
      View in: PubMed
    107. Davidson LA, Brown RE, Chang WC, Morris JS, Wang N, Carroll RJ, Turner ND, Lupton JR, Chapkin RS. Morphodensitometric analysis of protein kinase C beta(II) expression in rat colon: modulation by diet and relation to in situ cell proliferation and apoptosis. Carcinogenesis. 2000 Aug; 21(8):1513-9. PMID: 10910952.
      View in: PubMed
    108. Hong MY, Chapkin RS, Wild CP, Morris JS, Wang N, Carroll RJ, Turner ND, Lupton JR. Relationship between DNA adduct levels, repair enzyme, and apoptosis as a function of DNA methylation by azoxymethane. Cell Growth Differ. 1999 Nov; 10(11):749-58. PMID: 10593651.
      View in: PubMed
    109. Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs. Oncology (Switzerland). 90-100.
    110. Phase II study of saracatinib (AZD0530) in patients with previously treated metastatic colorectal cancer. Investigational New Drugs.
    111. Spatial modeling of annual minimum and maximum temperatures in Iceland. Meteorology and Atmospheric Physics. 116:43-61.
    112. Validation of an IGF-CTP scoring system for assessing hepatic reserve in egyptian patients with hepatocellular carcinoma. Oncotarget. 6:21193-21207.
    113. Robust, adaptive functional regression in functional mixed model framework. Journal of the American Statistical Association. 106:1167-1179.
    114. A New paradigm for clinical biomarker discovery and screening with mass spectrometry through biomedical image analysis principles. 1332-1335.
    115. Study of Mexican free-tailed bat chirp syllables. Journal of the American Statistical Association. 108:514-526.
    116. Discussion of nonparametric and semiparametric regression. Statistica Sinica. 14:615-621.
    117. Hierarchical Bayesian methods for integration of various types of genomics data. 5-8.
    118. Understanding the characteristics of mass spectrometry data through the use of simulation. Cancer Informatics. 1:41-52.
    119. Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer. British Journal of Cancer. 114:1352-1361.
    120. Refining prognosis in patients with hepatocellular carcinoma through incorporation of metabolic imaging biomarkers. European Journal of Nuclear Medicine and Molecular Imaging. 1-10.
    121. Functional Regression. Annual Review of Statistics and Its Application. 2:321-359.
    122. Utility of a molecular prescreening program in advanced colorectal cancer for enrollment on biomarker-selected clinical trials. Annals of Oncology. 27:1068-1074.
    123. Parametric and Nonparametric Methods for Understanding the Relationship between Carcinogen-Induced DNA Adduct Levels in Distal and Proximal Regions of the Colon. Journal of the American Statistical Association. 96:816-826.
    124. Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma. OncoTargets and Therapy. 9:773-780.
    125. Integrative analysis of multi-modal correlated imaging-genomics data in glioblastoma. 5-8.
    126. The work of Raymond J. Carroll.
    127. The consensus molecular subtypes of colorectal cancer. Nature Medicine. 21:1350-1356.
    128. Bevacizumab combined with capecitabine and oxaliplatin in patients with advanced adenocarcinoma of the small bowel or ampulla of vater. Cancer.
    129. Preface. Unknown Journal. ix-x.
    130. Wavelet-based functional mixed models. Journal of the Royal Statistical Society. Series B: Statistical Methodology. 68:179-199.
    131. Characterizing the patterns of clonal selection in circulating tumor DNA from patients with colorectal cancer refractory to anti-EGFR treatment. Annals of Oncology. 26:731-736.
    132. Functional CAR Models for Large Spatially Correlated Functional Datasets. Journal of the American Statistical Association. 111:772-786.
    133. Pre-processing mass spectrometry data. 79-102.
    134. Reply to A. Goyal et al. Journal of Clinical Oncology. 30:1019-1020.
    135. Statistical methods for proteomic biomarker discovery based on feature extraction or functional modeling approaches. Statistics and its Interface. 5:117-136.
    136. Online Variational Bayes Inference for High-Dimensional Correlated Data. Journal of Computational and Graphical Statistics. 25:426-444.
    137. Development and validation of insulin-like growth factor-1 score to assess hepatic reserve in hepatocellular carcinoma. Journal of the National Cancer Institute. 106.
    138. Bias, randomization, and ovarian proteomic data. Cancer Informatics. 1:9-14.
    139. Bayesian function-on-function regression for multilevel functional data. Biometrics. 71:563-574.
    140. Multilevel functional data analysis. 223-248.
    141. Using wavelet-based functional mixed models to characterize population heterogeneity in accelerometer profiles. Journal of the American Statistical Association. 101:1352-1364.
    142. Wavelet-Based Nonparametric Modeling of Hierarchical Functions in Colon Carcinogenesis. Journal of the American Statistical Association. 98:573-583.
    143. Erratum. Proteomics. 11:2359.
    144. Bayesian random segmentation models to identify shared copy number aberrations for array CGH data. Journal of the American Statistical Association. 105:1358-1375.
    145. Age-related changes in the non-linear mechanical strain response of human peripapillary sclera.
    146. Tumor microenvironment in gene signatures. Clinical Cancer Research. 22:3989-3991.
    147. Identification of differentially methylated loci using wavelet-based functional mixed models. Bioinformatics. 32:664-672.
    148. Rejoinder. Journal of the American Statistical Association. 98:591-597.
    149. The BLUPs are not "best" when it comes to bootstrapping. Statistics and Probability Letters. 56:425-430.
    150. Automated analysis of quantitative image data using isomorphic functional mixed models, with application to proteomics data. Annals of Applied Statistics. 5:894-923.
    151. A proposed staging system and stage-specific interventions for familial adenomatous polyposis. Gastrointestinal Endoscopy.
    MORRIS's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description